Sort
53,477 grants matching “addiction”
Efficacy and cost of HAART DOT in methadone clinics
$1,017,554Yeshiva University · R01 · FY2003 · DA
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES
$1,017,525Dorothy K Hatsukami · University Of Pittsburgh At Pittsburgh · U54 · FY2012 · DA
The Icahn School of Medicine at Mount Sinai (ISMMS) EPPIC-Net Specialized Clinical Center
$1,017,000Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · U24 · FY2019 · NS
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
$1,016,741Joshua D Lee · New York University School Of Medicine · R01 · FY2016 · AA
Center on Molecular and Cell Biology of Drug Abuse
$1,016,454University Of Minnesota Twin Cities · P50 · FY2004 · DA
Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses
$1,015,880Gracelyn Cruden · Chestnut Health Systems, Inc. · R33 · FY2024 · DA
Preclinical Testing of Antibody Therapy for METH Abuse
$1,015,797University Of Arkansas Med Scis Ltl Rock · P01 · FY2002 · DA
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$1,015,636University Of Miami School Of Medicine · U10 · FY2003 · DA
Appalachian Node
$1,015,427Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2022 · DA
9/24- Healthy Brain and Child Development National Consortium
$1,015,198Lauren S Wakschlag · Northwestern University At Chicago · U01 · FY2021 · DA
12/24 Healthy Brain and Child Development National Consortium
$1,015,189Elinor L. Sullivan · Oregon Health & Science University · U01 · FY2021 · DA
15/24- Healthy Brain and Child Development National Consortium
$1,015,066Matthew James Gurka · University Of Florida · U01 · FY2021 · DA
Genetics and Progression of Early-onset Substance Dependence and HIV Risk
$1,014,929Christian J Hopfer · University Of Colorado Denver · R01 · FY2014 · DA
University of Pennsylvania (UPENN) Overall Coordinating & Clinical Trial Site
$1,014,652Caryn Lerman · University Of Pennsylvania · U01 · FY2012 · DA
Hallucinogens and 5-HT Receptors: Mechanisms and Effects
$1,014,547Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2010 · DA
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$1,014,545Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2021 · CA
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
$1,014,204Fredric Schiffer · Mindlight, Llc · R44 · FY2023 · DA
Staying Off Substances: A Tailored Early Recovery Program for Teens
$1,014,179Kimberlee Jean Trudeau · Inflexxion, Inc. · R44 · FY2011 · DA
SCOR Application on Sex, Stress, and Cocaine Addiction
$1,014,134Yale University · P50 · FY2004 · DA
21/24 Healthy Brain and Child Development National Consortium
$1,013,921Douglas Carl Dean III · University Of Wisconsin-Madison · U01 · FY2021 · DA
2/24 Healthy Brain and Child Development National Consortium
$1,013,860Pat R Levitt · Children'S Hospital Of Los Angeles · U01 · FY2021 · DA
8/24 The Healthy Brain and Child Development National Consortium
$1,013,732Moriah E Thomason · New York University School Of Medicine · U01 · FY2021 · DA
Oncogenic mechanisms and molecular targets in myeloma
$1,013,664Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,013,664Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
RNA interference-based screens for molecular targets in cancer
$1,013,664Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA